Abbonarsi

A novel online calculator based on noninvasive markers (ALBI and APRI) for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma - 16/06/21

Doi : 10.1016/j.clinre.2020.09.001 
Jin-Yu Shi a, 1, Li-Yang Sun b, c, 1, Bing Quan b, c, 1, Hao Xing b, 1, Chao Li b, 1, Lei Liang b, 1, Timothy M. Pawlik d, Ya-Hao Zhou e, Hong Wang f, Wei-Min Gu g, Ting-Hao Chen h, Wan Yee Lau b, i, Feng Shen b, Nan-Ya Wang a, , Tian Yang b,
a The Cancer Center, the First Hospital of Jilin University, Changchun, China 
b Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai, China 
c Department of Clinical Medicine, Second Military Medical University (Naval Medical University), Shanghai, China 
d Department of Surgery, Ohio State University, Wexner Medical Center, Columbus, OH, United States 
e Department of Hepatobiliary Surgery, Pu’er People’s Hospital, Yunnan, China 
f Department of General Surgery, Liuyang People’s Hospital, Hunan, China 
g The First Department of General Surgery, The Fourth Hospital of Harbin, Heilongjiang, China 
h Department of General Surgery, Ziyang First People’s Hospital, Sichuan, China 
i Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, N.T., Hong Kong SAR, China 

Corresponding author at: Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Navy Medical University), No. 225, Changhai Road, Shanghai 200438, ChinaDepartment of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Navy Medical University)No. 225, Changhai RoadShanghai200438China⁎⁎Corresponding author at: The Cancer Center, the First Hospital of Jilin University, No. 71, Xinmin Street, Changchun, Jilin, ChinaThe Cancer Center, the First Hospital of Jilin UniversityNo. 71, Xinmin StreetChangchunJilinChina

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

pagine 11
Iconografia 3
Video 0
Altro 0

Highlights

Post-hepatectomy liver failure (PHLF) is a devastating complication.
Multivariable analysis identified high ALBI and APRI grades as independent risks of PHLF in both pre- and postoperative models.
The AUCs for the pre- and postoperative models were higher than APRI, ALBI, MELD and Child-Pugh scores in predicting PHLF.
Two online calculators that combined ALBI and APRI were proposed as useful tools for predicting the occurrence of PHLF.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Background and aim

Post-hepatectomy liver failure (PHLF) remains the primary cause of in-hospital mortality after hepatectomy. Identifying predictors of PHLF is important to improve surgical safety. We sought to identify the predictive accuracy of two noninvasive markers, albumin-bilirubin (ALBI) and aspartate aminotransferase to platelet count ratio index (APRI), to predict PHLF among patients with hepatocellular carcinoma (HCC), and to build up an online prediction calculator.

Methods

Patients who underwent resection for HCC between 2013 and 2016 at 6 Chinese hospitals were retrospectively analyzed. The independent predictors of PHLF were identified using univariate and multivariate analyses; derivative data were used to construct preoperative and postoperative nomogram models. Receiver operating characteristic (ROC) curves for the two predictive models, and ALBI, APRI, Child-Pugh, model for end-stage liver disease (MELD) scores were compared relative to predictive accuracy for PHLF.

Results

Among the 767 patients in the analytic cohort, 102 (13.3%) experienced PHLF. Multivariable logistic regression analysis identified high ALBI grade (>-2.6) and high APRI grade (>1.5) as independent risk factors associated with PHLF in both the preoperative and postoperative models. Two nomogram predictive models and corresponding web-based calculators were subsequently constructed. The areas under the ROC curves for the postoperative and preoperative models, APRI, ALBI, MELD and Child-Pugh scores in predicting PHLF were 0.844, 0.789, 0.626, 0.609, 0.569, and 0.560, respectively.

Conclusions

ALBI and APRI demonstrated more accurate ability to predict PHLF than Child-Pugh and MELD. Two online calculators that combined ALBI and APRI were proposed as useful preoperative and postoperative tools for individually predicting the occurrence of PHLF among patients with HCC.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : HCC, PHLF, ALBI, APRI, MELD, ROC, AUC, ALT, AST, NR, ASA, RLV, CSPH, BMI, TB, CT, MRI, OR, CI

Keywords : Hepatocellular carcinoma, Liver resection, Post-hepatectomy liver failure, Albumin-bilirubin, Aspartate transaminase to platelet ratio index, Prediction


Mappa


© 2020  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 45 - N° 4

Articolo 101534- luglio 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Drug-eluting bead transarterial chemoembolization is an effective downstaging option for subsequent radical treatments in patients with hepatocellular carcinoma: A cohort study
  • Liang Cai, Honglu Li, Jiang Guo, Wenpeng Zhao, Youjia Duan, Xiaopu Hou, Long Cheng, Hongliu Du, Xihong Shao, Zhenying Diao, Changqing Li
| Articolo seguente Articolo seguente
  • Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with non-alcoholic fatty liver disease
  • Cheryl Huang, Jun Jie Seah, Chin Kimg Tan, Jia Wen Kam, Jessica Tan, Eng Kiong Teo, Andrew Kwek, Yu Jun Wong, Malcolm Tan, Tiing Leong Ang, Rahul Kumar

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.